Results 161 to 170 of about 26,059 (187)
Some of the next articles are maybe not open access.
British journal of clinical pharmacology, 2012
U predavanju je dana definicija farmakoekonomike, vrste analiza, te primjena u praksi.
openaire +2 more sources
U predavanju je dana definicija farmakoekonomike, vrste analiza, te primjena u praksi.
openaire +2 more sources
The National medical journal of India, 2004
Pharmacoeconomics focuses on the costs and benefits of drug therapy and pharmacoeconomic evaluations provide a basis for resource allocation and utilization. It is increasingly becoming important for health policy decision-making. A pharmacoeconomic evaluation may be conducted as an economic assessment incorporated into clinical trials.
Jaya, Ahuja +3 more
openaire +1 more source
Pharmacoeconomics focuses on the costs and benefits of drug therapy and pharmacoeconomic evaluations provide a basis for resource allocation and utilization. It is increasingly becoming important for health policy decision-making. A pharmacoeconomic evaluation may be conducted as an economic assessment incorporated into clinical trials.
Jaya, Ahuja +3 more
openaire +1 more source
Interventional Pharmacoeconomics-A New Discipline for a Cost-Constrained Environment.
JAMA Oncology, 2019M. Ratain, D. Goldstein, A. Lichter
semanticscholar +1 more source
The Journal of the Association of Physicians of India, 2002
Today, spiraling costs of medical care coupled with limited resources have led to an explosive increase in the number of pharmacoeconomic analyses being carried out. The first step in a pharmacoeconomic analysis is to measure the costs and benefits of the therapeutic regimens being compared.
N S, Sule, R P, Nerurkar, S A, Kamath
openaire +1 more source
Today, spiraling costs of medical care coupled with limited resources have led to an explosive increase in the number of pharmacoeconomic analyses being carried out. The first step in a pharmacoeconomic analysis is to measure the costs and benefits of the therapeutic regimens being compared.
N S, Sule, R P, Nerurkar, S A, Kamath
openaire +1 more source
Pharmacoeconomics of Biosimilars: What Is There to Gain from Them?
Current Rheumatology Reports, 2016F. Araújo, J. Gonçalves, J. Fonseca
semanticscholar +1 more source